Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Boswellia serrata for pain sensitivity and pain modulation in healthy adults

Official title: Effect of Boswellia Serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers - a Randomized, Double-blind, Placebo-controlled, Cross-over Pilot Trial

Run by Medical University of Graz · NCT07109843 · Data updated 2026-11-12

Researchers will test whether Boswellia serrata extract can reduce pain sensitivity and change how the body modulates pain in healthy adults.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment12 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz, Styria)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedSeptember 24, 2025
Trial IDNCT07109843 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18 or older without chronic pain, major medical conditions, or use of excluded medications, and who are not pregnant or breastfeeding are eligible to participate.

Probably not a fit

People with chronic pain, renal or liver insufficiency, neurological/dermatological/cardiovascular diseases, or those taking anticoagulants, antidepressants, MAO inhibitors, CYP-modulating drugs, or St. John's Wort are excluded and would not benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled crossover study in healthy volunteers comparing Boswellia serrata extract with placebo. Participants will undergo quantitative sensory testing (QST) to measure peripheral and central sensitization and descending pain inhibitory pathways before and after each treatment period. The study uses well-defined exclusion criteria to avoid confounding by chronic pain, medications, or major medical conditions. Results aim to clarify whether observed clinical analgesic effects of Boswellia are linked to changes in pain processing mechanisms.

Why it matters

Potential benefit: If successful, the findings could point to a new, well-tolerated supplement approach that helps reduce pain sensitivity and guide treatments for chronic pain.

How similar studies have gone: Several clinical studies have suggested Boswellia serrata can relieve chronic pain, but effects on central and peripheral sensitization or pain modulation in human experimental models have not been previously established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: ≥18 years

Exclusion Criteria:

* Not pregnant or breastfeeding
* No renal or liver insufficiency
* No neurological/dermatological/cardiovascular diseases
* No chronic pain and/or use of analgesics
* No use of anticoagulants
* No use of antidepressants
* No use of MAO inhibitors
* No use of St. John's Wort
* No use of medications affecting the CYP mechanism
* No allergies to Boswellia serrata or capsaicin"

Where it's running

  • Medical University of Graz
    Graz, Styria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.